COVID-19: the hidden impact on mental health and drug addiction S Chiappini, A Guirguis, A John, JM Corkery, F Schifano Frontiers in psychiatry 11, 572335, 2020 | 184 | 2020 |
An insight into Z-drug abuse and dependence: an examination of reports to the European medicines agency database of suspected adverse drug reactions F Schifano, S Chiappini, JM Corkery, A Guirguis International Journal of Neuropsychopharmacology 22 (4), 270-277, 2019 | 150 | 2019 |
The use and impact of cognitive enhancers among university students: a systematic review S Sharif, A Guirguis, S Fergus, F Schifano Brain sciences 11 (3), 355, 2021 | 111 | 2021 |
Abuse of prescription drugs in the context of novel psychoactive substances (NPS): a systematic review F Schifano, S Chiappini, JM Corkery, A Guirguis Brain sciences 8 (4), 73, 2018 | 92 | 2018 |
New/emerging psychoactive substances and associated psychopathological consequences F Schifano, F Napoletano, S Chiappini, A Guirguis, JM Corkery, ... Psychological medicine 51 (1), 30-42, 2021 | 91 | 2021 |
The “endless trip” among the NPS users: psychopathology and psychopharmacology in the hallucinogen-persisting perception disorder. A systematic review L Orsolini, GD Papanti, D De Berardis, A Guirguis, JM Corkery, F Schifano Frontiers in Psychiatry 8, 301735, 2017 | 82 | 2017 |
Reorganization of substance use treatment and harm reduction services during the COVID-19 pandemic: a global survey SR Radfar, CAJ De Jong, A Farhoudian, M Ebrahimi, P Rafei, M Vahidi, ... Frontiers in Psychiatry 12, 639393, 2021 | 79 | 2021 |
Identification of new psychoactive substances (NPS) using handheld Raman spectroscopy employing both 785 and 1064 nm laser sources A Guirguis, S Girotto, B Berti, JL Stair Forensic science international 273, 113-123, 2017 | 75 | 2017 |
‘New/Designer Benzodiazepines’: an analysis of the literature and psychonauts’ trip reports L Orsolini, JM Corkery, S Chiappini, A Guirguis, A Vento, D De Berardis, ... Current neuropharmacology 18 (9), 809-837, 2020 | 73 | 2020 |
A global survey on changes in the supply, price, and use of illicit drugs and alcohol, and related complications during the 2020 COVID-19 pandemic A Farhoudian, SR Radfar, H Mohaddes Ardabili, P Rafei, M Ebrahimi, ... Frontiers in psychiatry 12, 646206, 2021 | 70 | 2021 |
Focus on over-the-counter drugs' misuse: a systematic review on antihistamines, cough medicines, and decongestants F Schifano, S Chiappini, A Miuli, A Mosca, MC Santovito, JM Corkery, ... Frontiers in psychiatry 12, 657397, 2021 | 65 | 2021 |
The clinical challenges of synthetic cathinones F Schifano, F Napoletano, D Arillotta, C Zangani, L Gilgar, A Guirguis, ... British journal of clinical pharmacology 86 (3), 410-419, 2020 | 64 | 2020 |
Assessing the 2004–2018 fentanyl misusing issues reported to an international range of adverse reporting systems F Schifano, S Chiappini, JM Corkery, A Guirguis Frontiers in Pharmacology 10, 428774, 2019 | 64 | 2019 |
Intended and unintended use of cathinone mixtures A Guirguis, JM Corkery, JL Stair, SB Kirton, M Zloh, F Schifano Human Psychopharmacology: Clinical and Experimental 32 (3), e2598, 2017 | 58 | 2017 |
Analysis of ‘legal high’substances and common adulterants using handheld spectroscopic techniques S Assi, A Guirguis, S Halsey, S Fergus, JL Stair Analytical methods 7 (2), 736-746, 2015 | 50 | 2015 |
The psychonauts’ world of cognitive enhancers F Napoletano, F Schifano, JM Corkery, A Guirguis, D Arillotta, C Zangani, ... Frontiers in Psychiatry 11, 546796, 2020 | 41 | 2020 |
Identifying new/emerging psychoactive substances at the time of COVID-19; a web-based approach V Catalani, D Arillotta, JM Corkery, A Guirguis, A Vento, F Schifano Frontiers in psychiatry 11, 632405, 2021 | 40 | 2021 |
Benefits and harms of ‘smart drugs’(nootropics) in healthy individuals F Schifano, V Catalani, S Sharif, F Napoletano, JM Corkery, D Arillotta, ... Drugs 82 (6), 633-647, 2022 | 39 | 2022 |
New psychoactive substances (NPS) and serotonin syndrome onset: A systematic review F Schifano, S Chiappini, A Miuli, JM Corkery, N Scherbaum, F Napoletano, ... Experimental Neurology 339, 113638, 2021 | 39 | 2021 |
The use of new psychoactive substances (NPS) in young people and their role in mental health care: a systematic review L Orsolini, S Chiappini, JM Corkery, A Guirguis, D Papanti, F Schifano Expert Review of Neurotherapeutics 19 (12), 1253-1264, 2019 | 35 | 2019 |